The reproductive toxicology studies are carried out primarily to assess the possible effects of drugs on reproductive performance and fertility.
At VIMTA, our team for developmental and reproductive toxicology is equipped with latest technologies and has the required expertise to cater to diverse requirements of developmental and reproductive toxicology studies, including neonatal and juvenile animal studies. The studies are designed to test the effect of drugs including small molecules and biologics on fertility, embryo fetal development, prenatal and postnatal development and maternal function. We also conduct studies for identification of endocrine disruptor functions, which include determination of serum hormone levels, estrous cycling, uterotrophic and Hershberger assays, uternine and vaginal histopathology and cell staging.
Our key services and capabilities include:
- Fertility (Male and / or Female) – Segment I
- Embryo-fetal Development – Segment II
- Prenatal and Postnatal Development, including Maternal Function – Segment III
- Neonatal and Juvenile Toxicity Studies
- Reproductive and Developmental Toxicity Screening Studies
- Combined Repeated Dose Toxicity Studies with Reproduction and Developmental Toxicity Screening
- One Generation Reproduction Toxicity Studies
- Two Generation Reproduction Toxicity Studies
- Extended One Generation Reproduction Toxicity Studies
- Developmental Neurotoxicity Studies
In Vivo specialty studies for Endocrine-Disrupting Chemicals
- Uterotrophic Bioassay in Rodents
- Hershberger Bioassay in Rodents